Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles may improve caffeine delivery for hair growth, offering a potential alternative to minoxidil for hair loss treatment.

The inhibitor DPP can promote hair growth.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Genes and hormones cause hair loss, with four genes contributing equally.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Most women with excessive hair growth have a hormonal cause.

HAIR may cause fetal loss by triggering different cell death processes in the uterus and placenta.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.